It has been found that H19 knockdown inhibits the expression of PPARγ, which results in the upregulation of miR-130a, and is considered an attenuating agent of NAFLD through inducing apoptosis in hepatic stellate cells [76]. This evidence concerns the gene H19 and metabolic dysfunction-associated steatotic liver disease.